ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,457Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 890

$1.22M Total Retail Price of All Prescriptions

Rank: 24 out of 890

570 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 570 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

18% of this provider’s 570 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 15,365 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 604 489 1 7
SIMVASTATIN 600 496 2 5
LEVOTHYROXINE SODIUM 473 434 3 2
MELOXICAM 473 430 3 18
METFORMIN HCL 460 338 5 6
POTASSIUM CHLORIDE 429 364 6 11
ATORVASTATIN CALCIUM 415 337 7 13
LISINOPRIL 414 312 8 4
HYDROCODONE-ACETAMINOPHEN 389 278 S3 9 3
OMEPRAZOLE 367 297 10 8
ZOLPIDEM TARTRATE 357 251 11 19
DONEPEZIL HCL 330 320 12 30
AMLODIPINE BESYLATE 328 260 13 1
NEXIUM 318 240 14 14
NAMENDA 270 258 15 36
GABAPENTIN 263 200 16 12
HYDROCHLOROTHIAZIDE 247 194 17 9
CLOPIDOGREL 236 169 18 28
PANTOPRAZOLE SODIUM 214 159 19 34
CITALOPRAM HBR 212 167 20 20
CYMBALTA 201 131 21 45
CARVEDILOL 188 127 22 22
CLONIDINE HCL 183 162 23 35
TAMSULOSIN HCL 181 169 24 32
EXFORGE 179 150 25 140
PLAVIX 168 118 26 42
DIOVAN 166 139 27 33
DIOVAN HCT 164 138 28 48
FLUTICASONE PROPIONATE 162 130 29 39
METOPROLOL TARTRATE 153 119 30 15
ESCITALOPRAM OXALATE 153 127 30 51
METOPROLOL SUCCINATE 145 100 32 17
WARFARIN SODIUM 142 106 33 24
AZITHROMYCIN 139 95 34 37
KLOR-CON M20 128 103 35 72
LANTUS 127 52 36 50
TRAMADOL HCL 124 76 37 16
TRAMADOL HCL-ACETAMINOPHEN 123 97 38 117
SYNTHROID 122 93 39 53
LIPITOR 120 108 40 77
ADVAIR DISKUS 120 94 40 52
SERTRALINE HCL 118 76 42 26
ALENDRONATE SODIUM 116 104 43 38
CRESTOR 115 88 44 25
CYCLOBENZAPRINE HCL 114 71 R 45 64
AMLODIPINE BESYLATE-BENAZEPRIL 113 96 46 41
CELEBREX 112 107 47 91
EXFORGE HCT 110 109 48 220
RISPERIDONE 110 83 48 78
DIGOXIN 106 92 50 65
HYDRALAZINE HCL 104 79 51 100
EXELON 104 104 51 113
FAMOTIDINE 102 87 53 90
SPIRIVA 101 66 54 66
RANITIDINE HCL 100 86 55 49
PROPRANOLOL HCL 99 88 56 141
ATENOLOL 99 63 56 23
ISOSORBIDE MONONITRATE ER 99 65 56 60
GLIMEPIRIDE 99 64 56 27
AMITRIPTYLINE HCL 93 61 R 60 43
LYRICA 93 45 60 71
BYSTOLIC 91 64 62 86
MECLIZINE HCL 90 71 63 97
CIPROFLOXACIN HCL 88 71 64 58
VERAPAMIL ER 86 76 65 87
PAROXETINE HCL 84 73 66 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 72 67 76
DIVALPROEX SODIUM 82 60 68 126
FENOFIBRATE 80 76 69 74
PRAVASTATIN SODIUM 80 62 69 10
DETROL LA 78 73 71 164
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 42 72 21
LEXAPRO 72 66 72 186
MEGESTROL ACETATE 71 54 R 74 92
FLUOXETINE HCL 71 60 74 63
LANTUS SOLOSTAR 71 46 74 102
METHYLPREDNISOLONE 69 54 77 109
DEXILANT 68 56 78 138
PRAMIPEXOLE DIHYDROCHLORIDE 67 57 79 175
ZETIA 67 48 79 81
VENTOLIN HFA 65 41 81 177
LOSARTAN POTASSIUM 64 44 82 29
TRICOR 63 45 83 98
CARBIDOPA-LEVODOPA 61 61 84 136
ENABLEX 60 60 85 248
TRIAMCINOLONE ACETONIDE 60 44 85 160
PROAIR HFA 58 23 87 55
PREDNISONE 57 42 88 47
POLYETHYLENE GLYCOL 3350 57 54 88 67
TRAZODONE HCL 56 53 90 40
SPIRONOLACTONE 55 34 91 85
AMITIZA 53 48 92 210
HUMALOG 51 38 93 214
LANSOPRAZOLE 51 41 93 171
NAPROXEN 50 14 95 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.